Following internal discussions at CeMM on human genome editing – prompted by recent reports on the birth of gene-edited babies using CRISPR technology in China – we distance ourselves from human trials performed without adequate ethical approval by the responsible institutions and in violation of both local regulations and the international consensus in the scientific community.

CeMM welcomes responsible research on understanding and advancing genome editing technology including CRISPR, which greatly benefits basic biomedical research and has great potential also for the treatment of many genetic diseases. Importantly, any such research must…

Kaan Boztug, Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD), is awarded a prestigious Consolidator Grant of the European Research Council (ERC) for research on human immune dysregulation.

Kaan Boztug, Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD), Adjunct PI at CeMM and Professor of Pediatrics at the Medical University of Vienna and St. Anna Children’s Hospital, receives the renowned funding by the ERC with a project duration of five years to decode disorders of the human immune regulation. After being granted a FWF START prize and an ERC Starting Grant in 2012,…

Do you want to work in an environment that promotes free-minded scientific creativity, and translate your findings to impact medical practice and improve healthcare?
Are you excited to gain a new understanding of the molecular physiology and pathology of humans?
Do you want to join an international group of highly collaborative and successful colleagues that help you achieve your training and research goals?
Are you a person who enjoys teamwork across disciplines and within a broader cultural and social context?

The next PhD Program of CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna will start in…

Who regulates the key regulator? The Superti-Furga laboratory at CeMM reports online in the journal Science about a newly discovered mechanism by which RAS proteins, central to cancer signaling, are regulated in their activity and localization.

Of the more than 23,000 genes in the human genome, only a handful assume a very central role in signal transduction and growth regulation. Of these, the three genes encoding RAS proteins are particularly important, as they are found mutated in over 25% of human cancers. The processes around the RAS gene products are also involved in a variety of rare human developmental disorders called the…

We are happy to announce that during Summer/Autumn we had a successful search for new CeMM and LBI-RUD Adjunct Principal Investigators.

A warm WELCOME to:

Miriam Unterlass (CeMM) - Materials Chemistry, Technical University of Vienna
Nuno Maulide (CeMM) – Organic Chemistry, University of Vienna
Andreas Villunger (CeMM/LBI-RUD) – Division of Developmental Immunology, Medical University of Innsbruck
Thomas Reiberger (LBI-RUD/CeMM) – Division of Gastroenterology and Hepatology, Medical University of Vienna
Georg Stary (LBI-RUD/CeMM) – Department of Dermatology, Medical University of Vienna

We were looking for MD and/or PhD scientists either at…

To start the academic year with a community experience CeMM had its yearly Outing on Friday, October 5, 2018. This year´s thematic focus was on traffic and public transport, and built on our previous SMART lecture held by architect and urban design consultant Jan Gehl on “Livable cities for the 21st century”.

We were very glad for the opportunity to visit the light rail manufacturing plant of Siemens Mobility GmbH in the 11th district of Vienna which is usually not open to visitors. After a short presentation and introduction we had guided tours through the production halls learning more about the impressive logistics of a successful global…

Thank you for the interest and applications! We will contact the candidates asap. CeMM and LBI-RUD plan to invite several candidates to a hearing, which will take place in the last week of September 2018.

Adjunct Principal Investigator Positions at LBI-RUD and CeMM, Vienna
Starting or consolidated level to begin in 2018/2019

CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences and LBI-RUD, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases have identical principles of excellence, competitiveness, internationality as well as mentoring and training, and both operate in a unique mode of…